Orthopedics This Week – One of Wall Street’s top research groups has concluded that the May 4 passage of the AHCA, if ultimately signed into law by President Trump, would likely reduce orthopedic procedure volumes 0.7% in 2018 and, cumulatively, cut overall volumes 1.2% in 2026.
WSJ – The international cyberattack that swept the globe has had some impact on the U.S. health-care system, as hospital systems scramble to prevent its further spread.
MDO – Dr. Justin Barad is a gamer, so it makes sense he would be drawn to virtual reality. As a high schooler, he started the computer science team he interned at.
CB Insights – Global funding to private medical device companies rose in 2016, reaching nearly $4B in 2016 across 479 deals. The United States receives a lot of attention when it comes to funding medical device startups, but private companies around the world are raising significant rounds.
mLIVE – “It is a good time to be at Stryker and a good time to be at Stryker in Kalamazoo,” Kevin A. Lobo said, following the medical technologies company’s 38th annual shareholders meeting Wednesday afternoon in Kalamazoo.
CB Insights – As medical device companies gain traction, large corporates such as Medtronic, Boston Scientific, and Teleflex are competing in the race to acquire private medical device startups targeting neurosurgery, orthopedics, and cardiology, among other areas.
What a Future!! – Since its inception in 2000, Da Vinci Surgical Robot has revolutionized the way surgeries are done. Da Vinci has been used on more than 2 million patients since it got FDA approval and is the only surgical robot that has that kind of record.
Becker’s Spine Review – The healthcare delivery system in the United States is considered the most expensive in the world, and the future need for joint replacements is sure to worsen the economic pressures.
FierceBiotech – BD has struck a $24 billion deal to buy C.R. Bard. The takeover will strengthen BD’s position in the markets for catheters, pumps and other items while also giving it a bigger presence in fast-growing fields including oncology and biosurgery.
Qmed – The medical device and equipment sector enjoyed a strong rebound in investment during the first quarter of this year. These 10 medical device and equipment companies closed the biggest funding rounds in the industry.
MassDevice – More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017. The situation suggests that even with the uncertainty around what the Trump administration in the U.S. is going to do, investors are confident that the future looks bright for the industry.
A federal judge in New Jersey yesterday transferred a sales rep poaching case between DJO Global and Stryker (NYSE:SYK) to Indiana because the quintet of ex-Stryker sales reps involved live there and most of the events in th case occurred in the Hoosier State.
In an exciting year for healthcare, orthopedic device companies underwent mergers and acquisitions, strove to find the most innovative solutions and made calculated decisions in the hopes of achieving long-term success as the market becomes increasingly competitive.
Dr. Matthew T. Hummel of Commonwealth Orthopaedic Centers performed the first total knee replacement surgery using new robotic-arm assisted technology at St. Elizabeth Healthcare — technology available at only a handful of medical centers in the nation.
Surgical robotics systems stole the show at this year’s annual meeting of the American Academy of Orthopaedic Surgeons, but analysts are struggling to assess what the rate of adoption and peak penetration will be for these robots.
These new orthopedic products generated a lot of buzz at last week’s meeting of the American Academy of Orthopaedic Surgeons.
Medical devices implanted in the body for drug delivery, sensing, or tissue regeneration usually come under fire from the host’s immune system.
If you walked through the sprawling exhibit floor of the San Diego Convention Center last week, you would have noticed products galore. Mannequins being pretend
Johnson & Johnson and Verily Life Sciences (formerly Google Life Sciences) have a joint venture to create the next generation of robotic surgery souped up
Spend enough time with Larry Smarr and, chances are, he’ll invite you to step inside his colon. Like more than a million Americans, Smarr has